AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration

Sweden

1 July 2018 - 30 June 2019

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration published between 1 July 2018 - 30 June 2019 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

AC FC
1 0.19

Outputs by subject (FC)

Subject AC FC
Life Sciences 1 0.19

Top articles by Altmetric score in current window

1 July 2018 - 30 June 2019

International vs. domestic collaboration by FC

  • 0% Domestic
  • 100% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by FC (0 total)

  • AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration, Sweden
  • Domestic institution

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Participating institutions

AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs